Treatment Options for Urogenital Dysfunction in Parkinson's Disease.
Urogenital dysfunction is commonly reported in Parkinson's disease (PD), and history taking and a bladder diary form the cornerstone of evaluation. The assessment of lower urinary tract (LUT) symptoms include urinalysis, ultrasonography, and urodynamic studies and help to evaluate concomitant urological pathologies such as benign prostate enlargement. Antimuscarinic medications are the first line treatment for overactive bladder (OAB) symptoms and solifenacin has been specifically studied in PD. Antimuscarininc drugs may exacerbate PD-related constipation and xerostomia, and caution is advised when using these medications in individuals where cognitive impairment is suspected. Desmopressin is effective for the management of nocturnal polyuria which has been reported to be common in PD. Intradetrusor injections of botulinum toxin have been shown to be effective for detrusor overactivity, however, are associated with the risk of urinary retention. Neuromodulation is a promising, minimally invasive treatment for PD-related OAB symptoms. Erectile dysfunction is commonly reported and first line treatments include phosphodiesterase-5 inhibitors. A patient-tailored approach is required for the optimal management of urogenital dysfunction in PD.
UCL Institute of Neurology, Queen Square, 7 Queen Square, London, WC1N 3BG, UK. a.batla@ucl.ac.uk.
Amit
A
Batla
Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Natalie
N
Tayim
Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Mahreen
M
Pakzad
Department of Uro-Neurology, The National Hospital for Neurology and Neurosurgery and UCL Institute of Neurology, Queen Square, London, UK.
Jalesh N
JN
Panicker
Bladder diary Parkinson’s disease; Detrusor overactivity; Erectile dysfunction; Incontinence; Lower urinary tract; Urodynamics
J Urol. 2000 Jan;163(1):5-12
10604303
Auton Neurosci. 2001 Sep 17;92(1-2):76-85
11570707
BJU Int. 2002 Jun;89(9):855-62
12010228
J Urol. 2003 Apr;169(4):1388-91
12629368
Neuroscience. 2003;120(3):871-5
12895527
Ann Neurol. 2004 Jan;55(1):118-20
14705120
Parkinsonism Relat Disord. 2004 Mar;10(3):181-7
15036175
Neurourol Urodyn. 2004;23(3):265-72
15098225
Neurourol Urodyn. 2004;23(7):689-96
15382192
J Spinal Cord Med. 2004;27(3):214-8
15478523
Clin Auton Res. 2005 Apr;15(2):76-82
15834763
J Neurol. 2005 Nov;252(11):1310-5
15895303
Neuroscience. 2005;135(1):299-303
16111828
Eur J Neurol. 2005 Nov;12(11):842-50
16241972
Lancet Neurol. 2006 Mar;5(3):235-45
16488379
Mov Disord. 2006 Jun;21(6):737-45
16570299
Urology. 2006 Apr;67(4):731-6; discussion 736
16618562
Arch Neurol. 2006 May;63(5):729-35
16682542
Mov Disord. 2007 Jan 15;22(2):220-5
17133504
Proc (Bayl Univ Med Cent). 2007 Jul;20(3):307-14
17637888
Urologiia. 2007 May-Jun;(3):15-9
17722614
Neurourol Urodyn. 2009;28(1):62-7
18837432
J Urol. 2009 May;181(5):2209-13
19296974
J Nutr Health Aging. 2009 Oct;13(8):672-6
19657549
Parkinsonism Relat Disord. 2010 Sep;16(8):531-4
20637678
Eur Urol. 2010 Dec;58(6):865-74
20934242
J Epidemiol Community Health. 1990 Sep;44(3):246-8
2148771
BJU Int. 2011 Jul;108(1):6-21
21676145
Adv Urol. 2011;2011:834753
21687581
J Clin Psychiatry. 2011 Jun;72(6):869-70
21733482
J Urol. 2011 Sep;186(3):960-4
21791351
Neurobiol Dis. 2012 Jun;46(3):565-71
22015601
Ther Adv Neurol Disord. 2011 Nov;4(6):375-83
22164191
Eur Urol. 2012 Nov;62(5):816-30
22397851
Neurourol Urodyn. 2012 Nov;31(8):1279-83
22488851
Eur Urol. 2012 Nov;62(5):877-90
22840350
Eur Urol. 2012 Dec;62(6):1040-60
22999811
Urology. 2013 Aug;82(2):313-20
23769122
Urology. 2014 Jan;83(1):22-7
24231202
J Urol. 1988 Jul;140(1):117-8
2454326
Chin Med J (Engl). 2014;127(5):878-81
24571881
Patient Prefer Adherence. 2014 Feb 12;8:191-8
24611001
Mov Disord. 2015 Feb;30(2):229-37
25449044
J Wound Ostomy Continence Nurs. 2015 Jan-Feb;42(1):94-9
25549314
JAMA Intern Med. 2015 Mar;175(3):401-7
25621434
Neurourol Urodyn. 2016 Jun;35(5):551-63
25810035
Parkinsonism Relat Disord. 2015 May;21(5):514-20
25814050
Lancet Neurol. 2015 Jul;14(7):720-32
26067125
Prog Urol. 2015 Nov;25(13):845-6
26544453
Mult Scler. 2016 Jun;22(7):855-61
26892318
Mov Disord Clin Pract. 2016 Jun 07;3(5):443-451
30363512
Mov Disord Clin Pract. 2015 Dec 24;3(2):168-172
30363570
J Urol. 1987 Oct;138(4):836-8
3656541
J Urol. 1986 May;135(5):966-8
3959249
Int Urol Nephrol. 1985;17(1):35-41
3997405
Br J Urol. 1985 Dec;57(6):652-6
4084724
Mov Disord. 1995 May;10(3):337-40
7651453
Neurourol Urodyn. 1993;12(1):1-7
8481726